Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression
The complexity of biological systems suggests that current definitions of molecular dysfunctions are essential distinctions of a complex phenotype. This is well seen in neurodegenerative diseases (ND), such as Alzheimer's disease (AD) and Parkinson's disease (PD), multi-factorial pathologi...
Main Authors: | Marios G. Krokidis, Themis P. Exarchos, Panagiotis Vlamos |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2021-04-01
|
Series: | Mathematical Biosciences and Engineering |
Subjects: | |
Online Access: | http://www.aimspress.com/article/doi/10.3934/mbe.2021094?viewType=HTML |
Similar Items
-
Molecular diagnostics of neurodegenerative disorders
by: Megha eAgrawal, et al.
Published: (2015-09-01) -
Omics-Driven Biomarkers of Psoriasis: Recent Insights, Current Challenges, and Future Prospects
by: Aydin B, et al.
Published: (2020-08-01) -
Editorial: Risk Factors and Outcome Predicating Biomarker of Neurodegenerative Diseases
by: Chaur-Jong Hu, et al.
Published: (2019-02-01) -
Histone Methylation Regulation in Neurodegenerative Disorders
by: Balapal S. Basavarajappa, et al.
Published: (2021-04-01) -
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
by: Margherita Grasso, et al.
Published: (2014-05-01)